Family Medicine in Oxford, NC
16 verified family medicine doctors in Oxford.
Family medicine physicians provide comprehensive primary care for patients of all ages, from newborns to seniors — managing everyday illness, chronic conditions, and preventive care.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. John Strittmatter, MD
Family Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Eric Buenviaje, MD
Family Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Michael Bobb, DO
Family Medicine
CMS Open Payments· $40.51 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$40.51
Total received
2
Transactions
2
Paying companies
Top paying companies
Among the 136,402 family medicine doctors we've analyzed, about 35% received any industry payment (median $151 among those who did). This doctor's total ranks around the 74th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US family medicine doctors.
Payments to Michael Bobb do not imply any wrongdoing. Many are meals, education, or research support.
Dr. John Anderson, MD
Family Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Andrew Stock, MD
Family Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Eugene Day, MD
Family Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Thomas Koinis, MD
Family Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Yashica Ruffin, MD
Family Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Shauna Guthrie, MD
Family Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Natalie Hobdy, MD
Family Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Richard Rogers, MD
Family Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Stephanie Goshorn, MD
Family Medicine
CMS Open Payments· $1,571 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,571
Total received
97
Transactions
25
Paying companies
Top paying companies
Among the 136,402 family medicine doctors we've analyzed, about 35% received any industry payment (median $151 among those who did). This doctor's total is higher than 97% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US family medicine doctors.
Payments to Stephanie Goshorn do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Julianne Tondreau, MD
Family Medicine
CMS Open Payments· $101.19 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$101.19
Total received
6
Transactions
2
Paying companies
Top paying companies
Among the 136,402 family medicine doctors we've analyzed, about 35% received any industry payment (median $151 among those who did). This doctor's total ranks around the 79th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US family medicine doctors.
Payments to Julianne Tondreau do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Alexa Namba, DO
Family Medicine
CMS Open Payments· $9,469 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$9,469
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 136,402 family medicine doctors we've analyzed, about 35% received any industry payment (median $151 among those who did). This doctor's total is higher than 99% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US family medicine doctors.
Payments to Alexa Namba do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Margo Faulk, MD
Family Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Marissa Mangini, MD
Family Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.